IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 5037 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Adaptive design clinical trials: Methodology, challenges and prospect

Mahajan Rajiv, Gupta Kapil

Year : 2010| Volume: 42| Issue : 4 | Page no: 201-207

   This article has been cited by
1 PMED: Optimal Bayesian Platform Trial Design with Multiple Endpoints
Tian He, Rachael Liu, Meizi Liu, Jianchang Lin
Journal of Biopharmaceutical Statistics. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Progress, development and challenges in amyotrophic lateral sclerosis clinical trials
Jasmine F. Ashhurst, Sicong Tu, Hannah C. Timmins, Matthew C. Kiernan
Expert Review of Neurotherapeutics. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Applications of artificial intelligence and machine learning in heart failure
Tauben Averbuch, Kristen Sullivan, Andrew Sauer, Mamas A Mamas, Adriaan A. Voors, Chris P. Gale, Marco Metra, Neal Ravindra, Harriette G.C. Van Spall
European Heart Journal - Digital Health. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 The benefits of covariate adjustment for adaptive multi-arm designs
Kim May Lee, David S. Robertson, Thomas Jaki, Richard Emsley
Statistical Methods in Medical Research. 2022; : 0962280222
[Pubmed]  [Google Scholar] [DOI]
5 Adaptive treatment allocation and selection in multi-arm clinical trials: a Bayesian perspective
Elja Arjas, Dario Gasbarra
BMC Medical Research Methodology. 2022; 22(1)
[Pubmed]  [Google Scholar] [DOI]
6 Applying concepts from “rapid” and “agile” implementation to advance implementation research
Andrew Quanbeck, Rose Garza Hennessy, Linda Park
Implementation Science Communications. 2022; 3(1): 21
[Pubmed]  [Google Scholar] [DOI]
7 Electronic Health Interventions for Patients With Breast Cancer: Systematic Review and Meta-Analyses
Anna C. Singleton, Rebecca Raeside, Karice K. Hyun, Stephanie R. Partridge, Gian Luca Di Tanna, Nashid Hafiz, Qiang Tu, Justin Tat-Ko, Stephanie Che Mun Sum, Kerry A. Sherman, Elisabeth Elder, Julie Redfern
Journal of Clinical Oncology. 2022;
[Pubmed]  [Google Scholar] [DOI]
8 Lung Cancer Clinical Trials with a Seamless Phase II/III Design: Systematic Review
Dionysios Palermos, Theodoros N. Sergentanis, Maria Gavriatopoulou, Panagiotis Malandrakis, Theodora Psaltopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos
Journal of Clinical Medicine. 2022; 11(23): 7176
[Pubmed]  [Google Scholar] [DOI]
9 Indian Pharmaceutical Industries Current Status and Togetherness to Overcome Speed Breakers in Term of Quality Issues to make India as a Global Pharma Destination
Vikas Rathee, Kapil Pihwal, Neelam Pawar, Sheikh Aamir, Mohammad S. Alam, Kavita Bahmani
Applied Drug Research, Clinical Trials and Regulatory Affairs. 2021; 8(1): 19
[Pubmed]  [Google Scholar] [DOI]
10 Brain Organoids: Tiny Mirrors of Human Neurodevelopment and Neurological Disorders
Anuradha Yadav, Brashket Seth, Rajnish Kumar Chaturvedi
The Neuroscientist. 2021; 27(4): 388
[Pubmed]  [Google Scholar] [DOI]
11 Blinding, sham, and treatment effects in randomized controlled trials for back pain in 2000–2019: A review and meta-analytic approach
Brian Freed, Brian Williams, Xiaolu Situ, Victoria Landsman, Jeehyoung Kim, Alex Moroz, Heejung Bang, Jongbae J Park
Clinical Trials. 2021; 18(3): 361
[Pubmed]  [Google Scholar] [DOI]
12 RCTs and other clinical trial designs in Ayurveda: A review of challenges and opportunities
Pushya A. Gautama
Journal of Ayurveda and Integrative Medicine. 2021; 12(3): 556
[Pubmed]  [Google Scholar] [DOI]
13 Challenges in Evaluating Safety and Efficacy in Drug Development for Rare Diseases: A Review for Pharmacists
Kanya K. Shah, Stephen Kogut, Angela Slitt
Journal of Pharmacy Practice. 2021; 34(3): 472
[Pubmed]  [Google Scholar] [DOI]
14 Adaptive design implementation in confirmatory trials: methods, practical considerations and case studies
Qing Li, Jianchang Lin, Yunzhi Lin
Contemporary Clinical Trials. 2020; 98: 106096
[Pubmed]  [Google Scholar] [DOI]
15 Including non-concurrent control patients in the analysis of platform trials: is it worth it?
Kim May Lee, James Wason
BMC Medical Research Methodology. 2020; 20(1)
[Pubmed]  [Google Scholar] [DOI]
16 Adaptive Design of Clinical Trials: A Sequential Learning Approach
Zhengli Wang, Stefanos Zenios
SSRN Electronic Journal. 2020;
[Pubmed]  [Google Scholar] [DOI]
17 An investigation of the impact of futility analysis in publicly funded trials
Benjamin GO Sully,Steven A Julious,Jon Nicholl
Trials. 2014; 15(1): 61
[Pubmed]  [Google Scholar] [DOI]
18 How can attrition rates be reduced in cancer drug discovery?
Lucas Moreno,Andrew DJ Pearson
Expert Opinion on Drug Discovery. 2013; 8(4): 363
[Pubmed]  [Google Scholar] [DOI]
19 Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
Antman, E., Weiss, S., Loscalzo, J.
Wiley Interdisciplinary Reviews: Systems Biology and Medicine. 2012; 4(4): 367-383
[Pubmed]  [Google Scholar]
20 Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
Elliott Antman,Scott Weiss,Joseph Loscalzo
Wiley Interdisciplinary Reviews: Systems Biology and Medicine. 2012; 4(4): 367
[Pubmed]  [Google Scholar] [DOI]
21 Adaptive trial design: Its growing role in clinical research and implications for pharmacists
Cirulli, J., McMillian, W.D., Saba, M., Stenehjem, D.
American Journal of Health-System Pharmacy. 2011; 68(9): 807-813
[Pubmed]  [Google Scholar]
22 Adaptive design - an innovative tool in drug development
Brahmachari, B., Bhatt, A.
Indian Journal of Medical Research. 2011; 133(3): 243-245
[Pubmed]  [Google Scholar]
23 Implications of comparative effectiveness research for radiation oncology
Justin E. Bekelman,Anand Shah,Stephen M. Hahn
Practical Radiation Oncology. 2011; 1(2): 72
[Pubmed]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow